{
    "clinical_study": {
        "@rank": "164873", 
        "arm_group": [
            {
                "arm_group_label": "Formula + placebo", 
                "arm_group_type": "Placebo Comparator"
            }, 
            {
                "arm_group_label": "Formula + probiotic", 
                "arm_group_type": "Experimental", 
                "description": "Formula + probiotic"
            }, 
            {
                "arm_group_label": "Breastfed + probiotic", 
                "arm_group_type": "Experimental", 
                "description": "Breastfed + probiotic"
            }, 
            {
                "arm_group_label": "Breastfed + placebo", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "Effect, tolerance and safety of a supplementation with a probiotic on the risk of\n      gastrointestinal infections, on growth, and on gut microbiota in healthy newborn term\n      infants born by Cesarean section. Exploratory comparison between a probiotic vs. placebo in\n      the formula-fed and in the breastfed feeding groups."
        }, 
        "brief_title": "Cesarean Section Study", 
        "condition": [
            "Diarrhea", 
            "Atopic Dermatitis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Dermatitis", 
                "Dermatitis, Atopic", 
                "Diarrhea"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  written informed consent must be obtained from legal guardian(s) prior to\n             randomization or any study related procedures\n\n          -  healthy newborns\n\n          -  born by Cesarean section\n\n          -  singleton birth\n\n          -  Age at enrollment in the study < 24h\n\n          -  birth weight \u2265 2500g and \u2264 4300g\n\n          -  gestational age \u2265 37 weeks and \u2264 42 weeks\n\n        Exclusion Criteria:\n\n          -  congenital diseases or malformations that may inhibit growth\n\n          -  prenatal and/or postnatal diseases\n\n          -  parents are expected to have difficulty complying with the feeding regime\n\n          -  planned re-admittance to the hospital in the first 14 days of life\n\n          -  antibiotic treatment at the time of enrollment in the study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "24 Hours", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "740", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01992497", 
            "org_study_id": "12.14.INF"
        }, 
        "intervention": {
            "arm_group_label": [
                "Formula + probiotic", 
                "Breastfed + probiotic"
            ], 
            "intervention_name": "Probiotic", 
            "intervention_type": "Dietary Supplement"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Cesarean section, probiotic, formula fed, gut microbiota", 
        "lastchanged_date": "May 22, 2014", 
        "location": {
            "contact": {
                "last_name": "Michael Radke, MD", 
                "phone": "00493312415902"
            }, 
            "facility": {
                "address": {
                    "city": "Potsdam", 
                    "country": "Germany", 
                    "zip": "14467"
                }, 
                "name": "Klinikum Ernst v. Bergmann GmbH"
            }, 
            "investigator": {
                "last_name": "Michael Radke, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "4", 
        "official_title": "Effect,Tolerance and Safety of a Supplementation With a Probiotic in Healthy Newborn Term Infants Born by Cesarean Section Over a 12 Months Period Study", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Ethics Commission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Number of diarrhea episodes  between a probiotic vs. placebo", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01992497"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Diarrhea duration between a probiotic vs. placebo", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "source": "Nestl\u00e9", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Nestl\u00e9", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}